214 related articles for article (PubMed ID: 9747815)
1. Predictive factors for late toxicity after endobronchial brachytherapy: a multivariate analysis.
Hennequin C; Tredaniel J; Chevret S; Durdux C; Dray M; Manoux D; Perret M; Bonnaud G; Homasson JP; Chotin G; Hirsch A; Maylin C
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):21-7. PubMed ID: 9747815
[TBL] [Abstract][Full Text] [Related]
2. [High-dose rate endobronchial brachytherapy: results and complications in 189 patients].
Taulelle M; Chauvet B; Vincent P; Félix-Faure C; Bucciarelli B; Garcia R; Reboul F
Bull Cancer Radiother; 1996; 83(3):127-34. PubMed ID: 8977562
[TBL] [Abstract][Full Text] [Related]
3. Treatment of roentgenographically occult endobronchial carcinoma with external beam radiotherapy and intraluminal low-dose-rate brachytherapy: second report.
Saito M; Yokoyama A; Kurita Y; Uematsu T; Tsukada H; Yamanoi T
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):673-80. PubMed ID: 10837951
[TBL] [Abstract][Full Text] [Related]
4. Primary radiotherapy with endobronchial high-dose-rate brachytherapy boost for inoperable lung cancer: long-term results.
Rochet N; Hauswald H; Stoiber EM; Hensley FW; Becker HD; Debus J; Lindel K
Tumori; 2013; 99(2):183-90. PubMed ID: 23748812
[TBL] [Abstract][Full Text] [Related]
5. High dose rate endobronchial brachytherapy in the management of primary and recurrent bronchogenic malignancies.
Gustafson G; Vicini F; Freedman L; Johnston E; Edmundson G; Sherman S; Pursel S; Komic M; Chen P; Borrego JC
Cancer; 1995 May; 75(9):2345-50. PubMed ID: 7712446
[TBL] [Abstract][Full Text] [Related]
6. [Endobronchial brachytherapy: technique and indications].
Hennequin C; Bleichner O; Trédaniel J; Maylin C
Cancer Radiother; 2003 Feb; 7(1):33-41. PubMed ID: 12648715
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for massive hemoptysis after endobronchial brachytherapy in patients with tracheobronchial malignancies.
Hara R; Itami J; Aruga T; Kozuka T; Nakajima K; Yamashita H; Uno T; Morita T; Itoh H; Nomura T
Cancer; 2001 Nov; 92(10):2623-7. PubMed ID: 11745197
[TBL] [Abstract][Full Text] [Related]
8. The use of high dose rate endobronchial brachytherapy to palliate symptomatic recurrence of previously irriadiated lung cancer.
Kubaszewska M; Skowronek J; Chicheł A; Kanikowski M
Neoplasma; 2008; 55(3):239-45. PubMed ID: 18348661
[TBL] [Abstract][Full Text] [Related]
9. Curative irradiation of limited endobronchial carcinomas with high-dose rate brachytherapy. Results of a pilot study.
Pérol M; Caliandro R; Pommier P; Malet C; Montbarbon X; Carrie C; Ardiet JM
Chest; 1997 May; 111(5):1417-23. PubMed ID: 9149603
[TBL] [Abstract][Full Text] [Related]
10. Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor?
Langendijk JA; Tjwa MK; de Jong JM; ten Velde GP; Wouters EF
Radiother Oncol; 1998 Nov; 49(2):175-83. PubMed ID: 10052884
[TBL] [Abstract][Full Text] [Related]
11. Local determinants of response to endobronchial high-dose rate brachytherapy in bronchogenic carcinoma.
Ofiara L; Roman T; Schwartzman K; Levy RD
Chest; 1997 Oct; 112(4):946-53. PubMed ID: 9377957
[TBL] [Abstract][Full Text] [Related]
12. [Intrabronchial curietherapy. Experiences at Hôpital Saint-Louis after the treatment of 149 patients].
Trédaniel J; Hennequin C; Zalcman G; Gossot D; Lavergne F; Colin P; Manoux D; Perret M; Gerber F; Maylin C; Hirsch A
Rev Mal Respir; 1997 Dec; 14(6):465-72. PubMed ID: 9496605
[TBL] [Abstract][Full Text] [Related]
13. High dose-rate intraluminal irradiation in bronchogenic carcinoma. Technique and results.
Nori D; Allison R; Kaplan B; Samala E; Osian A; Karbowitz S
Chest; 1993 Oct; 104(4):1006-11. PubMed ID: 7691481
[TBL] [Abstract][Full Text] [Related]
14. Endobronchial brachytherapy and external-beam radiotherapy in patients with endobronchial obstruction and extrabronchial extension.
Gejerman G; Mullokandov EA; Bagiella E; Blaivas A; Beitler JJ
Brachytherapy; 2002; 1(4):204-10. PubMed ID: 15062168
[TBL] [Abstract][Full Text] [Related]
15. Irradiated volume and the risk of fatal hemoptysis in patients submitted to high dose-rate endobronchial brachytherapy.
Carvalho Hde A; Gonçalves SL; Pedreira W; Gregório MG; de Castro I; Aisen S
Lung Cancer; 2007 Mar; 55(3):319-27. PubMed ID: 17129634
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical benefits of the low dose rate endobronchial irradiation of malignant airway obstructions.
Spásová I; Petera J
Neoplasma; 2001; 48(3):234-40. PubMed ID: 11583295
[TBL] [Abstract][Full Text] [Related]
17. High dose rate endobronchial brachytherapy in combination with external beam radiotherapy for stage III non-small cell lung cancer.
Anacak Y; Mogulkoc N; Ozkok S; Goksel T; Haydaroglu A; Bayindir U
Lung Cancer; 2001 Nov; 34(2):253-9. PubMed ID: 11679184
[TBL] [Abstract][Full Text] [Related]
18. High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients.
Ozkok S; Karakoyun-Celik O; Goksel T; Mogulkoc N; Yalman D; Gok G; Bolukbasi Y
Lung Cancer; 2008 Dec; 62(3):326-33. PubMed ID: 18482780
[TBL] [Abstract][Full Text] [Related]
19. [Endobronchial brachytherapy: the Saint-Louis Hospital experience].
Hennequin C; Trédaniel J; Durdux C; Zalcman G; Dray M; Manoux D; Perret M; Housset M; Hirsch A; Maylin C
Cancer Radiother; 1997; 1(2):159-64. PubMed ID: 9273188
[TBL] [Abstract][Full Text] [Related]
20. [The role of high dose rate (HDR) brachytherapy in advanced non-small cell lung cancer].
Makarewicz R
Pneumonol Alergol Pol; 2002; 70(5-6):265-77. PubMed ID: 12518625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
